Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment

Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment

Pancreatic cancer remains a formidable challenge due to limited treatment options and its aggressive nature. In recent years, the naturally occurring anticancer compound juglone has emerged as a potential therapeutic candidate, showing promising results in inhibiting tumor growth and inducing cancer...

Full description

Bibliographic Details
Main Authors: Vidhi M. Shah, Syed Rizvi, Alexander Smith, Motoyuki Tsuda, Madeline Krieger, Carl Pelz, Kevin MacPherson, Jenny Eng, Koei Chin, Michael W. Munks, Colin J. Daniel, Adel Al-Fatease, Galip Gürkan Yardimci, Ellen M. Langer, Jonathan R. Brody, Brett C. Sheppard, Adam WG. Alani, Rosalie C. Sears
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceutics
Subjects:
juglone
drug delivery
pancreatic cancer
micelles
nanotechnology
Online Access:https://www.mdpi.com/1999-4923/15/12/2651

Similar Items

Similar Items